NEK2 and ovarian cancer: KMPlotter analysis of NEK2 expression reveals positive patient survival correlations with esophageal squamous cell carcinoma, ovarian cancer, and thymomas (HR < 1, p-value < 0.05) and negative correlations with survival in esophageal adenocarcinoma, head and neck squamous cell carcinoma, kidney renal cell carcinoma, kidney renal papillary carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, pancreatic ductal carcinoma, sarcoma, and thyroid carcinoma (HR > 1, p-value < 0.05) (Table 1).